Shah Preetam 4
4 · Cidara Therapeutics, Inc. · Filed Mar 20, 2024
Insider Transaction Report
Form 4
Shah Preetam
CFO & CBO
Transactions
- Award
Common Stock
2024-03-15+108,750→ 335,960 total - Award
Employee Stock Option (right to buy)
2024-03-15+217,500→ 217,500 totalExercise: $0.68Exp: 2034-03-14→ Common Stock (217,500 underlying)
Footnotes (2)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on March 15, 2024. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2025, 2026, and 2027, subject to continuous service through each such vesting date.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 15, 2024.